Press Releases

Date Title
24 May 2022 Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy
18 May 2022 Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care
5 May 2022 Illumina Reports Financial Results for First Quarter of Fiscal Year 2022
5 May 2022 Illumina and Deerfield Management partner to accelerate drug development
28 Apr 2022 Illumina To Webcast Upcoming Investor Conference
25 Apr 2022 Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children
14 Apr 2022 Illumina to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022
12 Apr 2022 Illumina Expands Access to Genomics in Latin America through New State-of-the-Art Solution Center
11 Apr 2022 John Frank Joins Illumina as Chief Public Affairs Officer
7 Apr 2022 Illumina Releases Annual Corporate Social Responsibility Report
16 Mar 2022 Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications
15 Mar 2022 Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
14 Mar 2022 Illumina Welcomes Carissa Rollins as Chief Information Officer
21 Feb 2022 Illumina To Webcast Upcoming Investor Conference
10 Feb 2022 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021
3 Feb 2022 Illumina To Webcast Upcoming Investor Conferences
3 Feb 2022 Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer
24 Jan 2022 Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia
20 Jan 2022 Illumina to Announce Fourth Quarter & Full Year 2021 Financial Results on Thursday, February 10, 2022
10 Jan 2022 Illumina collaborates with Nashville Biosciences to accelerate medicines development
10 Jan 2022 Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care
10 Jan 2022 Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
10 Jan 2022 Illumina delivers 2021 results ahead of expectations, strong 2022 guidance and deep pipeline of long-term growth opportunities at 2022 J.P. Morgan Healthcare Conference
5 Jan 2022 Illumina Enters Co-Development Partnership with SomaLogic